BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7196995)

  • 1. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
    Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
    Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.
    Crawford CG; van Alphen GW; Cook HW; Lands WE
    Life Sci; 1978 Sep; 23(12):1255-62. PubMed ID: 101727
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.
    Kadowitz PJ; Nandiwada PA; Spannhake EW; Rosenson RS; McNamara DB; Hyman AL
    Chest; 1983 May; 83(5 Suppl):72S-74S. PubMed ID: 6404609
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H; Stegmeier K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissociation of vascular resistance with endocrine pancreas secretion: the effects of epoxymethano analogs of PGH2.
    Akpan JO; Hurley MC; Pek S; Lands WE
    Prostaglandins Med; 1981 Dec; 7(6):473-81. PubMed ID: 7034020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulceration induced by an endoperoxide analog and by indomethacin in the canine stomach.
    Whittle BJ; Moncada S
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():373-8. PubMed ID: 6221616
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
    Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
    Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandin H2 on perinatal pulmonary circulation.
    Tod ML; Cassin S; McNamara DB; Kadowitz PJ
    Pediatr Res; 1986 Jun; 20(6):565-9. PubMed ID: 3714368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contractile responses of intrapulmonary vessels from three species to arachidonic acid and an epoxymethano analog of PGH2.
    Gruetter CA; McNamara DB; Hyman AL; Kadowitz PJ
    Can J Physiol Pharmacol; 1978 Apr; 56(2):206-15. PubMed ID: 638873
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of human lymph contractility by prostaglandins and thromboxane.
    Sinzinger H; Kaliman J; Mannheimer E
    Lymphology; 1984 Jun; 17(2):43-5. PubMed ID: 6381904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism.
    Johnston MG; Feuer C
    J Pharmacol Exp Ther; 1983 Aug; 226(2):603-7. PubMed ID: 6410049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal vascular responsiveness to arachidonic acid in experimental diabetes.
    Quilley J; McGiff JC
    Br J Pharmacol; 1990 Jun; 100(2):336-40. PubMed ID: 2116203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.